| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.16 | 0.3 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.3 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.13 | 0.3 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |